In 2020, the U.S. peripheral vascular device market size was valued at $7.1 billion, with over 8.26 million peripheral vascular procedures performed each year. The market size is expected to increase and reach $10.4 billion by 2026. Throughout this medical market research, we analyzed 67 peripheral vascular companies across the United States and used our comprehensive

The total market for cardiac rhythm management devices in Europe is growing at a rate of 3.9%, which will take the 2018 market value of €2.2 billion up to €2.9 billion by 2025. Reprocessed diagnostic electrophysiology (EP) catheters accounted for a significant percentage of all diagnostic EP catheters used. Reprocessed catheters have a much lower

Industry Trends Heart failure affects over five million people annually in the U.S. alone and is the costliest cardiovascular illness, with upwards of $30 billion spent on managing heart failure each year. Cardiac rhythm management devices, such as pacemakers, ICDs and CRT devices, are implanted in patients with arrhythmias to correct cardiac pacing and/or to

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the

Industry Trends There are a few components to the heart valve market, including tissue and mechanical non-percutaneous artificial heart valves. Of these two, tissue heart valves are generally preferred over mechanical valves, due to their higher levels of biocompatibility. Tissue valves, which are also known as bioprosthetic valves, are harvested from either human donors or

The full report suite on the European market for cardiac surgery devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVR) devices, transcatheter aortic valve implantation (TAVI) devices, devices used to perform on and off-pump coronary artery bypass procedures, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), artificial heart devices, patent foramen ovale (PFO) closure devices, atrial septal defect (ASD) closure devices and ventricular septal defect (VSD) closure devices.

The full report suite on the European market for cardiac surgery devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVR) devices, transcatheter aortic valve implantation (TAVI) devices, devices used to perform on and off-pump coronary artery bypass procedures, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), artificial heart devices, patent foramen ovale (PFO) closure devices, atrial septal defect (ASD) closure devices and ventricular septal defect (VSD) closure devices.

This is a global physcian survey regarding end-user attitudes and perceptions toward percutaneous coronary intervention, transcatheter aortic valve replacement, and drug coated balloons. Reponses were collected in person, from cardiologists and surgeons in attendance at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual conference.

Industry Trends A major driver of growth in the cardiac surgery market is the aging population. As the population ages, the rate of heart failure will increase. In addition, the elderly is often not suitable for open heart surgery. The aging population also drives the growth of minimally invasive procedures, such as transcatheter heart valve

The full report suite on the U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound machines, tip guidance devices, catheter securement devices, syringes and needles.

The full report suite on the U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound machines, tip guidance devices, catheter securement devices, syringes and needles.

The full report suite on the U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound machines, tip guidance devices, catheter securement devices, syringes and needles.

The full report suite on the U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound machines, tip guidance devices, catheter securement devices, syringes and needles.

The global peripherally inserted central catheters market size is estimated to increase over the forecast period to exceed $850 million in 2026.  The majority of the global peripherally inserted central catheters market share was controlled by Becton Dickinson and AngioDynamics. Overall, this global market research includes an analysis of peripherally inserted central catheters companies spawning

The global peripheral intravenous catheters market size is estimated to increase over the forecast period to reach almost $2 billion in 2026.  The majority of the global peripheral intravenous catheters market share was controlled by Becton Dickinson and B. Braun. Overall, this global market research includes an analysis of peripheral intravenous catheters companies spawning across more

The full report suite on the U.S. market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midlines, dialysis catheters, ultrasound machines, tip guidance devices, catheter securement devices, syringes and needles.